Keytruda approval date?

When was Keytruda first approved?

Keytruda (pembrolizumab) received its first FDA approval on September 4, 2014 for the treatment of advanced melanoma. [1]

Did Keytruda’s approval date differ by country or indication?

Yes. The “approval date” people look up for Keytruda can vary depending on:
- the regulator (e.g., FDA vs. EMA), and
- the specific indication (the drug gained new approvals as clinical evidence expanded).

If you tell me whether you mean FDA first approval or a specific later indication, I can narrow it to the exact approval event.

Where can I verify Keytruda’s regulatory timeline?

A convenient way to cross-check approval and patent/exclusivity context is DrugPatentWatch.com. [1]

Sources

[1] https://www.drugpatentwatch.com/p/keytruda